LifeStance Health Group, Inc.
LFST
$6.45
-$0.08-1.23%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 17.43% | 16.34% | 10.56% | 10.83% | 15.99% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.43% | 16.34% | 10.56% | 10.83% | 15.99% |
| Cost of Revenue | 18.45% | 16.46% | 10.42% | 8.49% | 9.51% |
| Gross Profit | 15.41% | 16.08% | 10.86% | 15.90% | 31.35% |
| SG&A Expenses | 1.81% | 12.70% | 2.77% | 7.09% | 10.80% |
| Depreciation & Amortization | -8.43% | -10.31% | -24.70% | -39.04% | -33.96% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.45% | 14.14% | 6.22% | 4.71% | 6.68% |
| Operating Income | 959.53% | 1,710.86% | 81.02% | 110.01% | 107.47% |
| Income Before Tax | 271.28% | 184.95% | 73.73% | 92.91% | 76.83% |
| Income Tax Expenses | 300.40% | 507.83% | -427.90% | -700.28% | -126.55% |
| Earnings from Continuing Operations | 264.06% | 118.08% | 83.71% | 103.36% | 84.18% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 264.06% | 118.08% | 83.71% | 103.36% | 84.18% |
| EBIT | 959.53% | 1,710.86% | 81.02% | 110.01% | 107.47% |
| EBITDA | 92.61% | 34.61% | 261.31% | 134.75% | 2,534.03% |
| EPS Basic | 260.96% | 117.83% | 84.01% | 103.21% | 84.72% |
| Normalized Basic EPS | 287.79% | 189.02% | 72.73% | 93.42% | 72.93% |
| EPS Diluted | 246.77% | 114.00% | 83.69% | 103.00% | 83.58% |
| Normalized Diluted EPS | 283.21% | 187.80% | 72.73% | 93.42% | 72.93% |
| Average Basic Shares Outstanding | 1.72% | 1.74% | 1.93% | 1.84% | 3.54% |
| Average Diluted Shares Outstanding | 4.09% | 2.24% | 1.93% | 3.81% | 3.54% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |